These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23926054)

  • 1. Simvastatin treatment showed no prophylactic effect in influenza virus-infected mice.
    Glück B; Schmidtke M; Walther M; Meerbach A; Wutzler P
    J Med Virol; 2013 Nov; 85(11):1978-82. PubMed ID: 23926054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
    Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
    Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.
    Ohgitani E; Kita M; Mazda O; Imanishi J
    Arch Virol; 2014 Feb; 159(2):267-75. PubMed ID: 23979178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kolaviron Improves Morbidity and Suppresses Mortality by Mitigating Oxido-Inflammation in BALB/c Mice Infected with Influenza Virus.
    Awogbindin IO; Olaleye DO; Farombi EO
    Viral Immunol; 2015 Sep; 28(7):367-77. PubMed ID: 26200137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.
    Simeonova L; Gegova G; Galabov AS
    Antiviral Res; 2012 Aug; 95(2):172-81. PubMed ID: 22617756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
    Wu J; Zhang F; Fang F; Chang H; Wang F; Yang Z; Sun B; Chen Z
    Vaccine; 2010 Mar; 28(15):2775-81. PubMed ID: 20117261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice.
    Choi HJ; Song JH; Kwon DH
    Phytother Res; 2012 Mar; 26(3):462-4. PubMed ID: 21728202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
    Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection.
    Kawase M; He F; Kubota A; Harata G; Hiramatsu M
    Lett Appl Microbiol; 2010 Jul; 51(1):6-10. PubMed ID: 20438618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.
    Norton EB; Clements JD; Voss TG; Cárdenas-Freytag L
    J Virol; 2010 Mar; 84(6):2983-95. PubMed ID: 20053748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-killed Lactobacillus gasseri TMC0356 protects mice against influenza virus infection by stimulating gut and respiratory immune responses.
    Kawase M; He F; Kubota A; Yoda K; Miyazawa K; Hiramatsu M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):280-8. PubMed ID: 22098223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.
    Xiuying P; Jianping L; Ruofeng S; Liye Z; Xuehong W; Yan L
    Can J Physiol Pharmacol; 2012 Feb; 90(2):123-30. PubMed ID: 22260349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    Saluja V; Visser MR; Ter Veer W; van Roosmalen ML; Leenhouts K; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2010 Nov; 28(50):7963-9. PubMed ID: 20946860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemin ameliorates influenza pneumonia by attenuating lung injury and regulating the immune response.
    Wang C; Zhang Y; Han L; Guo L; Zhong H; Wang J
    Int J Antimicrob Agents; 2017 Jan; 49(1):45-52. PubMed ID: 27884416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.